GMED - Latest News

Globus Medical, Inc. (GMED), operates in Healthcare / Medical - Devices, trades on NYSE.

Market capitalization stands near $11.63B. Trailing twelve-month P/E ratio is 19.90. Beta to the broader market is 0.95.

The article list below shows the most recent GMED headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.

Recent GMED Headlines

GMED vs. MDT: Which Medical Stock Has More Upside Potential?

zacks.com - Jun 29, 2026

Globus Medical or Medtronic? See why Globus Medical's stronger growth, innovation and analyst upside may give it the edge despite a richer valuation.

Why Globus Medical (GMED) is a Top Value Stock for the Long-Term

zacks.com - Jun 26, 2026

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

GMED vs. PEN: Which Stock Should Value Investors Buy Now?

zacks.com - Jun 22, 2026

Investors looking for stocks in the Medical - Instruments sector might want to consider either Globus Medical (GMED) or Penumbra (PEN). But which of

Here's How Macro Trends and Currency Headwind Restrict GMED's Growth

zacks.com - Jun 22, 2026

Globus Medical faces inflation, geopolitical and currency pressures as rising costs and FX losses cloud margin flexibility and international growth.

Globus Medical (GMED) Surges 5.1%: Is This an Indication of Further Gains?

zacks.com - Jun 22, 2026

Globus Medical (GMED) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate r

How News Affects GMED Options Pricing

Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track GMED's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.

Frequently asked GMED news questions

What is the latest GMED news headline?

The most recent GMED headline (Jun 29, 2026) is "GMED vs. MDT: Which Medical Stock Has More Upside Potential?". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.

How fresh is the GMED news on this page?

News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.

What GMED news moves options pricing?

Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.

How can I track unusual GMED options activity related to news?

Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.